North America Multiplex Assay Market 2024-2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	111 Pages	Triton Market Research	March, 2024	TRTN18685716

Best Price Guarantee
Price	from $1,500
Length	111 Pages
Publisher	Triton Market Research
Published Date	March, 2024
SKU	TRTN18685716

North America Multiplex Assay Market 2024-2032

Market Outlook

Triton’s research states that the North America multiplex assay market is estimated to progress with a CAGR of 8.53% during the projected years 2024-2032. Canada and the United States are evaluated in this region.

In Canada, there has been a notable rise in the incidence of new cancer cases. Data from the Canadian Medical Association Journal reveals that in 2022, an estimated 233,900 new cases of cancer were diagnosed. Among the most prevalent types were lung, breast, prostate, and colorectal cancers. This rise in cancer cases significantly elevates the demand for multiplex assays for precise diagnosis and treatment.

The increasing popularity of multiplex assays, in contrast to singleplex and traditional assays, is significantly propelling market expansion in the United States. Multiplex assays provide various advantages, such as sample consumption reduction through miniaturization, enhanced operational efficiency, simplicity in use, and lowered labor expenses. These advantages are collectively fostering the wider adoption of multiplex assays, thereby driving the United States market.

Competitive Outlook

The key companies listed in the market include Abcam Limited, Bio-Rat Laboratories, Qiagen NV, Siemens Healthineers AG, and Seegene Inc.

1. North America Multiplex Assay Market- Summary
2. Industry Outlook: 2.1. Impact Analysis On The Multiplex Assay Market; 2.1.1. Impact Of Covid-19 On The Multiplex Assay Market; 2.2. Porter’s Five Forces Model; 2.2.1. Threat Of New Entrants; 2.2.2. Threat Of Substitute Products; 2.2.3. Bargaining Power Of Buyers; 2.2.4. Bargaining Power Of Suppliers; 2.2.5. Competitive Rivalry; 2.3. Key Buying Impact Analysis; 2.3.1. Analyte Coverage; 2.3.2. Speed; 2.3.3. Multiplexing Capability; 2.3.4. Ease Of Use; 2.3.5. Automation; 2.4. Market Attractiveness Index; 2.5. Key Market Strategies; 2.5.1. Contracts And Partnerships; 2.5.2. Business Expansions & Divestitures; 2.5.3. Acquisitions & Mergers; 2.5.4. Product Launches & Developments; 2.6. Market Drivers; 2.6.1. Adoption Of Personalized Medicines; 2.6.2. High Adoption Of Multiplex Assays Over Traditional Methods; 2.6.3. Increasing Prevalence Of Chronic Diseases; 2.7. Market Challenges; 2.7.1. Issues Related To Cross-reactivity And Assay Interference; 2.7.2. Challenge In Achieving Adequate Assay Range; 2.7.3. Dearth Of Skilled Professionals; 2.8. Market Opportunities; 2.8.1. Technological Advancements In Assay Platforms; 2.8.2. Rapid Growth Of Companion Diagnostics; 2.8.3. Growth In Drug Discovery Initiatives; 2.9. Analyst Perspective
3. North America Multiplex Assay Market - By Product And Service: 3.1. Reagents And Consumables; 3.2. Instruments And Accessories; 3.3. Software And Services
4. North America Multiplex Assay Market - By Type: 4.1. Protein-based Multiplex Assay; 4.2. Nucleic Acid-based Multiplex Assay; 4.3. Other Multiplex Assays
5. North America Multiplex Assay Market - By Application: 5.1. Research And Development; 5.2. Clinical Diagnostics; 5.3. Companion Diagnostics
6. North America Multiplex Assay Market - By Technology: 6.1. Multiplex Protein Microarray; 6.2. Multiplex Pcr; 6.3. Other Technologies
7. North America Multiplex Assay Market - By Industry Vertical: 7.1. Pharmaceutical & Biotechnology Companies; 7.2. Research Institutes; 7.3. Clinical Laboratories; 7.4. Hospitals
8. North America Multiplex Assay Market – By Country Outlook: 8.1. United States; 8.1.1. United States Multiplex Assay Market Forecast & Prospects; 8.2. Canada; 8.2.1. Canada Multiplex Assay Market Forecast & Prospects
9. Competitive Landscape: 9.1. Abcam Limited; 9.1.1. Overview; 9.1.2. Product Portfolio; 9.2. Agilent Technologies Inc; 9.2.1. Overview; 9.2.2. Product Portfolio; 9.2.3. Key Strengths; 9.2.4. Key Challenges; 9.3. Becton, Dickinson And Company (Bd); 9.3.1. Overview; 9.3.2. Product Portfolio; 9.3.3. Key Strengths; 9.3.4. Key Challenges; 9.4. Bio-rad Laboratories Inc; 9.4.1. Overview; 9.4.2. Product Portfolio; 9.4.3. Key Strengths; 9.4.4. Key Challenges; 9.5. Bio-techne Corporation; 9.5.1. Overview; 9.5.2. Product Portfolio; 9.6. F. Hoffmann-la Roche Ltd; 9.6.1. Overview; 9.6.2. Product Portfolio; 9.6.3. Key Strengths; 9.6.4. Key Challenges; 9.7. Illumina Inc; 9.7.1. Overview; 9.7.2. Product Portfolio; 9.7.3. Key Strengths; 9.7.4. Key Challenges; 9.8. Merck Millipore; 9.8.1. Overview; 9.8.2. Product Portfolio; 9.9. Olink Proteomics Ab; 9.9.1. Overview; 9.9.2. Product Portfolio; 9.10. Qiagen Nv; 9.10.1. Overview; 9.10.2. Product Portfolio; 9.10.3. Key Strengths; 9.10.4. Key Challenges; 9.11. Randox Laboratories Ltd; 9.11.1. Overview; 9.11.2. Product Portfolio; 9.12. Seegene Inc; 9.12.1. Overview; 9.12.2. Product Portfolio; 9.13. Siemens Healthineers Ag; 9.13.1. Overview; 9.13.2. Product Portfolio; 9.13.3. Key Strengths; 9.13.4. Key Challenges; 9.14. Thermo Fisher Scientific Inc; 9.14.1. Overview; 9.14.2. Product Portfolio; 9.14.3. Key Strengths; 9.14.4. Key Challenges
10. Research Methodology & Scope: 10.1. Research Scope & Deliverables; 10.2. Sources Of Data; 10.3. Research Methodology
List Of Tables: Table 1: North America Multiplex Assay Market, By Country Outlook, Historical Years, 2020-2023 (In $ Million); Table 2: North America Multiplex Assay Market, By Country Outlook, Forecast Years, 2024-2032 (In $ Million); Table 3: Contracts And Partnerships; Table 4: List Of Business Expansions & Divestitures; Table 5: Acquisitions & Mergers; Table 6: List Of New Product Launches & Developments; Table 7: North America Multiplex Assay Market, By Product And Service, 2024-2032 (In $ Million); Table 8: North America Multiplex Assay Market, By Type, 2024-2032 (In $ Million); Table 9: North America Multiplex Assay Market, By Application, 2024-2032 (In $ Million); Table 10: North America Multiplex Assay Market, By Technology, 2024-2032 (In $ Million); Table 11: North America Multiplex Assay Market, By Industry Vertical, 2024-2032 (In $ Million); Table 12: North America Multiplex Assay Market, By Country Outlook, 2024-2032 (In $ Million
List Of Figures: Figure 1: North America Multiplex Assay Market, By Product And Service, 2023 & 2032 (In %); Figure 2: North America Multiplex Assay Market, By Reagents And Consumables, 2024-2032 (In $ Million); Figure 3: North America Multiplex Assay Market, By Instruments And Accessories, 2024-2032 (In $ Million); Figure 4: North America Multiplex Assay Market, By Software And Services, 2024-2032 (In $ Million); Figure 5: North America Multiplex Assay Market, By Type, 2023 & 2032 (In %); Figure 6: North America Multiplex Assay Market, By Protein-based Multiplex Assay, 2024-2032 (In $ Million); Figure 7: North America Multiplex Assay Market, By Nucleic Acid-based Multiplex Assay, 2024-2032 (In $ Million); Figure 8: North America Multiplex Assay Market, By Other Multiplex Assays, 2024-2032 (In $ Million); Figure 9: North America Multiplex Assay Market, By Application, 2023 & 2032 (In %); Figure 10: North America Multiplex Assay Market, By Research And Development, 2024-2032 (In $ Million); Figure 11: North America Multiplex Assay Market, By Clinical Diagnostics, 2024-2032 (In $ Million); Figure 12: North America Multiplex Assay Market, By Companion Diagnostics, 2024-2032 (In $ Million); Figure 13: North America Multiplex Assay Market, By Technology, 2023 & 2032 (In %); Figure 14: North America Multiplex Assay Market, By Multiplex Protein Microarray, 2024-2032 (In $ Million); Figure 15: North America Multiplex Assay Market, By Multiplex Pcr, 2024-2032 (In $ Million); Figure 16: North America Multiplex Assay Market, By Other Technologies, 2024-2032 (In $ Million); Figure 17: North America Multiplex Assay Market, By Industry Vertical, 2023 & 2032 (In %); Figure 18: North America Multiplex Assay Market, By Pharmaceutical & Biotechnology Companies, 2024-2032 (In $ Million); Figure 19: North America Multiplex Assay Market, By Research Institutes, 2024-2032 (In $ Million); Figure 20: North America Multiplex Assay Market, By Clinical Laboratories, 2024-2032 (In $ Million); Figure 21: North America Multiplex Assay Market, By Hospitals, 2024-2032 (In $ Million); Figure 22: North America Multiplex Assay Market, By Country Outlook, 2023 & 2032 (In %); Figure 23: United States Multiplex Assay Market 2024-2032 (In $ Million); Figure 24: Canada Multiplex Assay Market 2024-2032 (In $ Million)